{"id":22540,"date":"2024-01-12T09:15:18","date_gmt":"2024-01-12T08:15:18","guid":{"rendered":"https:\/\/k2info.w.uib.no\/?p=22540"},"modified":"2024-01-12T09:15:44","modified_gmt":"2024-01-12T08:15:44","slug":"global-health-edctp3-work-programme-2024-published","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/en\/2024\/01\/12\/global-health-edctp3-work-programme-2024-published\/","title":{"rendered":"Global Health EDCTP3 Work Programme 2024 Published"},"content":{"rendered":"<p>The Global Health European and Developing Countries Clinical Trials Partnership 3 Joint Undertaking (<a href=\"https:\/\/globalhealth-edctp3.eu\/\">GH EDCTP3 JU<\/a>) has released its\u00a0<a href=\"https:\/\/globalhealth-edctp3.eu\/resources\/work-programme-2024\">Work Programme for 2024<\/a>.<\/p>\n<p>In 2024, the GH EDCTP3 JU will distribute \u20ac140 million through two calls, which are planned to be launched on 18 January 2024, with a stage 1 deadline of 4 April 2024:<\/p>\n<p><!--more--><\/p>\n<p>The<strong> HORIZON-JU-GH-EDCTP3-2024-01-two-stage<\/strong> call covers six topics for Research and Innovation Actions (RIA):<\/p>\n<ul>\n<li>Developing novel, innovative HIV therapeutics for reducing the disease burden of HIV in sub-Saharan Africa<\/li>\n<li>Research on existing Malaria vaccines and development of new promising candidates<\/li>\n<li>Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa<\/li>\n<li>Tackling Antimicrobial Resistance (AMR) through R&amp;D in novel and existing antimicrobials<\/li>\n<li>New tools, technologies and approaches for vector control in sub-Saharan Africa<\/li>\n<li>Innovative digital health solutions for sub-Saharan Africa<\/li>\n<\/ul>\n<p>The <strong>HORIZON-JU-GH-EDCTP3-2024-02-two-stage<\/strong> call will include one topic for Coordination and Support Actions (CSA):<\/p>\n<ul>\n<li>Global Health EDCTP3 JU training fellowship with a return phase.<\/li>\n<\/ul>\n<p>The full description of the topics will be available when the calls open.<\/p>","protected":false},"excerpt":{"rendered":"<p>The Global Health European and Developing Countries Clinical Trials Partnership 3 Joint Undertaking (GH EDCTP3 JU) has released its\u00a0Work Programme for 2024. In 2024, the GH EDCTP3 JU will distribute \u20ac140 million through two calls, which are planned to be&hellip;<\/p>\n<p class=\"more-link-p\"><a class=\"more-link\" href=\"https:\/\/k2info.w.uib.no\/en\/2024\/01\/12\/global-health-edctp3-work-programme-2024-published\/\">Read more &rarr;<\/a><\/p>","protected":false},"author":2783,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[],"class_list":["post-22540","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/users\/2783"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=22540"}],"version-history":[{"count":2,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22540\/revisions"}],"predecessor-version":[{"id":22542,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22540\/revisions\/22542"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=22540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=22540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=22540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}